Cart
sales@molnova.com
6PGD-IN-S3
CAS No. 5539-66-2
6PGD-IN-S3( 6PGD Inhibitor S3 | S3 | Danthron methyl derivative )
Catalog No. M27840 CAS No. 5539-66-2
6PGD-IN-S3 is an inhibitor of 6-phosphogluconate dehydrogenase (6PGD).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 28 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name6PGD-IN-S3
-
NoteResearch use only, not for human use.
-
Brief Description6PGD-IN-S3 is an inhibitor of 6-phosphogluconate dehydrogenase (6PGD).
-
Description6PGD-IN-S3 is an inhibitor of 6-phosphogluconate dehydrogenase (6PGD).
-
In Vitro——
-
In Vivo——
-
Synonyms6PGD Inhibitor S3 | S3 | Danthron methyl derivative
-
PathwayMetabolic Enzyme/Protease
-
TargetDehydrogenase
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number5539-66-2
-
Formula Weight254.241
-
Molecular FormulaC15H10O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOc1cccc2C(=O)c3cccc(O)c3C(=O)c12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.H Kikukawa, et al. Production of cis-11-eicosenoic acid by Mortierella fungi. J Appl Microbiol. 2015 Mar;118(3):641-7.
molnova catalog
related products
-
WAY-311610
WAY-311610 is an 11β-hydroxysteroid dehydrogenase HSD11B1 inhibitor that inhibits the 11β-HSD1 enzyme with an IC = 0.34 μM.It can be used to study neuropathic pain, inflammatory pain, and occipital neuralgia.
-
Sibiricose A5
Sibiricose A5 is a lactate dehydrogenase inhibitor it displays antidepressant-like and antioxidant actions. Sibiricose A5 can protect PC12 cells damage induced by P. tenuifolia.
-
LDHA-IN-3
LDHA-IN-3 (1-(phenylseleno)-4-(trifluoromethyl) benzene) is a potent non-competitive lactate dehydrogenase (LDHA) inhibitor with an IC50 value of 145.2 nM.LDHA-IN-3 is a selenobenzene compound that can be used in cancer research.
